New Genomic Test Could Help Millions of Breast Cancer Patients Avoid Chemotherapy
A groundbreaking genomic test has been developed that could allow millions of breast cancer patients to forgo chemotherapy. This test helps identify patients who can safely skip chemotherapy, offering significant relief and improved treatment paths.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (37/100)Sources
Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy
Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes ‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy Millions of women with breast cancer could be spared chemotherapy with a groundbreaking genomic test, according to the results of a trial that could transform healthcare guidelines worldwide. Treatment for breast cancer, the world’s most prevalent form of the disease, involves surgery to remove tum...
By Andrew Gregory in Chicago
Read full article →Genetic test could offer breast cancer patients chance to skip chemo - The Times
Genetic test could offer breast cancer patients chance to skip chemo The Times
Read full article →Millions of breast cancer patients could avoid chemotherapy with new genome test
Doctors said the test shows people with certain forms of the disease can safely avoid chemotherapy
By Nicole Wootton-Cane
Read full article →
